Vyant Bio
![AxoSim, organoid, Vyant Bio, asset sales, neuroscience, Biotech](https://pharmtales.com/wp-content/uploads/2023/10/AxoSim-acquires-Vyants-organoid-tech-for-brain-disorder-research.jpg)
AxoSim acquires Vyant’s organoid tech for brain disorder research
Anika Sharma
AxoSim, a New Orleans-based drug discovery biotech, has successfully completed the acquisition of the neuroscience research assets from Vyant Bio’s ...
AxoSim, a New Orleans-based drug discovery biotech, has successfully completed the acquisition of the neuroscience research assets from Vyant Bio’s ...